1. Home
  2. PDSB vs FONR Comparison

PDSB vs FONR Comparison

Compare PDSB & FONR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PDSB
  • FONR
  • Stock Information
  • Founded
  • PDSB 2005
  • FONR 1978
  • Country
  • PDSB United States
  • FONR United States
  • Employees
  • PDSB N/A
  • FONR N/A
  • Industry
  • PDSB Biotechnology: Pharmaceutical Preparations
  • FONR Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • Sector
  • PDSB Health Care
  • FONR Health Care
  • Exchange
  • PDSB Nasdaq
  • FONR Nasdaq
  • Market Cap
  • PDSB 84.2M
  • FONR 95.7M
  • IPO Year
  • PDSB N/A
  • FONR 1987
  • Fundamental
  • Price
  • PDSB $1.45
  • FONR $15.22
  • Analyst Decision
  • PDSB Strong Buy
  • FONR
  • Analyst Count
  • PDSB 3
  • FONR 0
  • Target Price
  • PDSB $14.00
  • FONR N/A
  • AVG Volume (30 Days)
  • PDSB 296.4K
  • FONR 9.4K
  • Earning Date
  • PDSB 11-14-2024
  • FONR 02-12-2025
  • Dividend Yield
  • PDSB N/A
  • FONR N/A
  • EPS Growth
  • PDSB N/A
  • FONR N/A
  • EPS
  • PDSB N/A
  • FONR 1.42
  • Revenue
  • PDSB N/A
  • FONR $102,006,089.00
  • Revenue This Year
  • PDSB N/A
  • FONR N/A
  • Revenue Next Year
  • PDSB N/A
  • FONR N/A
  • P/E Ratio
  • PDSB N/A
  • FONR $10.70
  • Revenue Growth
  • PDSB N/A
  • FONR 0.70
  • 52 Week Low
  • PDSB $1.30
  • FONR $14.05
  • 52 Week High
  • PDSB $6.68
  • FONR $24.05
  • Technical
  • Relative Strength Index (RSI)
  • PDSB 34.16
  • FONR 47.95
  • Support Level
  • PDSB $1.37
  • FONR $15.03
  • Resistance Level
  • PDSB $1.50
  • FONR $15.40
  • Average True Range (ATR)
  • PDSB 0.13
  • FONR 0.29
  • MACD
  • PDSB 0.00
  • FONR 0.03
  • Stochastic Oscillator
  • PDSB 28.03
  • FONR 70.41

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

About FONR Fonar Corporation

Fonar Corp is a United States-based company which is engaged in the business of designing, manufacturing, selling and servicing magnetic resonance imaging (MRI) scanners, which utilize MRI technology for the detection and diagnosis of human disease, abnormalities, other medical conditions, and injuries. The company operates through two segments namely Manufacturing and servicing of medical equipment; and the Management of diagnostic imaging centers, which generates a vast majority of the revenue.

Share on Social Networks: